Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Migraine Survey in Gulf Region |
Migraine | United Arab Emirates | NCT06237062 | |
|
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy |
Primary IgA Nephropathy | Phase3 |
Argentina Australia Belgium Brazil China Colombia Czechia Denmark France Germany Hong Kong India Israel Italy Japan Korea, Republic of Malaysia Netherlands Norway Singapore Sweden Taiwan Thailand Turkey United Kingdom United States View All
|
NCT04557462 |
|
Study Evaluating Effectiveness and Adherence of Inclisiran Plus Standard of Care (SoC) Lipid-lowering Therapy Compared to SoC in ASCVD |
Primary Hypercholesterolemia, Mixed Dyslipidemia |
Austria China Israel Malaysia Saudi Arabia Switzerland United Arab Emirates United Kingdom View All
|
NCT05399992 | |
|
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan |
Prostate Cancer | Phase2 | Japan | NCT05114746 |
|
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection |
Melanoma | China | NCT04666272 | |
|
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers |
Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma, Carcinoma, Renal Cell, Carcinoma, Ovarian Epithelial, Nasopharyngeal Carcinoma, Carcinoma, Thymic, Anal Cancer, Mesothelioma, Esophagogastric Cancer, High Microsatellite Instability Colorectal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms | Phase1 |
Canada Germany Hong Kong Italy Japan Singapore Spain Taiwan United States View All
|
NCT05544929 |
|
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis |
Diffuse Cutaneous Systemic Sclerosis | Phase2 |
Korea, Republic of Taiwan Thailand Turkey United States View All
|
NCT06470048 |
|
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors |
Polycythemia Vera | Phase4 | Germany | NCT05853458 |
|
Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies |
B-cell Non-Hodgkin Lymphoma (B-NHL), B-cell Acute Lymphoblastic Leukemia (B-ALL) | Phase1 |
Belgium France Israel Italy Japan Singapore Spain United States View All
|
NCT05397496 |
|
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab |
Extensive Stage Small Cell Lung Cancer | Phase1, Phase2 |
France Germany Spain United Kingdom United States View All
|
NCT05142696 |